|
Today's Headlines
In light of recent healthcare revolutions, Formulary understands how important it is to develop new and better connections between patients, care providers, and payers. That is why we are launching FormularyWatch, a new brand aimed at helping you—the clinical pharmacist and the hospital and managed care pharmacy decision-maker—manage day-to-day clinical operations. » Full article
|
|
EDITOR'S PICK
Depression is a disease state that is commonly underdiagnosed and undertreated in patients over aged 65 years. Elderly patients may differ from younger patients in the presentation of symptoms and in the prevalence of comorbidities. Risk factors for the development of depression are different for elderly patients. Treatment may also be dissimilar, including response and response time to treatment. Treatment should be tailored to the individual patient in the geriatric population to optimize therapeutic outcomes. Pharmacists can be vigilant of comorbidities and medications that potentially increase the risk of depression in the elderly. Pharmacists can play a significant role in advocating for the screening and treatment of this disease state. They are in a unique position to improve patient outcomes in late-life depression. » Full article
|
|
Despite some key pieces of federal legislation passed in recent years, most drugs—about 93%—are still not studied in neonates. Os that researchers have studied in this vulnerable population and that bear labels reflecting the changes in pediatric prescribing information, only about half (54%) are used in the neonatal intensive care unit. » Full article
|
|
Last week, the New England Compounding Center's owners and insurers agreed to establish a $100 million compensation fund for its creditors, including the victims who were injured after receiving injections of contaminated steroids produced by the now bankrupt NECC. Victims have until Wednesday, January 15 to submit their claims in the case. » Full article
|
|
Ongoing studies may lead FDA to stiffen its bioequivalence rules for generic antiepileptic drugs and others with so-called narrow therapeutic indices, according to research presented at the American Epilepsy Society annual meeting recently in Washington, D.C., according to MedPage Today. » Full article
|
|
Continuing Education
This month, Drug Topics offers the second of a 2-part CPE series, "MTM considerations in multiple sclerosis." Earn up to 2 credits by completing this knowledge-based activity. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at
www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career.
|
|
Like
Tweet
